Home > PS Ratio > LYKA LABS

LYKA LABS
PS (Price/Sales) Ratio

The Current P/S Ratio of LYKA LABS is 2.26.

Share Price ₹85.9Sep 25,2026
Market Cap ₹311.0 Cr
Sales-TTM₹137.7 CrTTM-Consolidated Results
Price/Sales2.26xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of LYKA LABS is calculated as :

Current Market Cap [ ₹311.0 Cr] as on Sep 25,2026

(/) Sales [ ₹137.7 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.26x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for LYKA LABS , the investors are currently willing to pay '2.26 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !

The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.

Historical PS (Price/Sales) ratio chart of LYKA LABS


PS Ratio Performance Analysis for LYKA LABS

- LYKA LABS 's latest p/e ratio is 2.26x.

- LYKA LABS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 2.49x.

- LYKA LABS 's operated at median p/e ratio of 2.6x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.

- LYKA LABS 's p/e ratio hit its five-year low in Mar2026 of 1.24x.


How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
LYKA LABS 137.72.26311.0
SUN PHARMACEUTICAL INDUSTRIES LTD59,910.57.42444,717.0
DIVIS LABORATORIES LTD11,230.022.72255,115.0
TORRENT PHARMACEUTICALS LTD15,723.012.06189,613.0
CIPLA LTD28,324.43.99112,876.0
DR REDDYS LABORATORIES LTD33,227.93.02100,395.0
MANKIND PHARMA LTD14,737.96.94102,247.0
LUPIN LTD29,966.63.1995,573.6
ZYDUS LIFESCIENCES LTD28,591.74.19119,900.0
AUROBINDO PHARMA LTD34,935.32.8298,464.4
LAURUS LABS LTD7,269.614.87108,116.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.26x
Max industry PS 22.72x
Median industry PS 4.19x
Average industry PS 7.59x



You may also like the below Video Courses